Medical-tech company Stryker Corp. said Tuesday it has named Timothy Scannell president and chief operating officer, effective Aug. 1.
The company is making the change as David Floyd, group president, orthopaedics, is retiring on June 30, 2019. Scannell started his career with Stryker’s endoscopy business in 1990, serving in sales and marketing roles.
For almost a decade, he has been group president, recently overseeing medsurg and neurotechnology. Stryker shares were not active premarket, but have gained 12% in 2018, while the S&P 500 has gained 4%.
By Ciara Linnane
Novo Nordisk has announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has provided a positive opinion for the company’s Sogroya therapy. The once-weekly treatment – also known as somapacitan – is for the replacement of endogenous growth hormone (GH) in aged children three years and older.
Medtronic is set to acquire EOFlow, the South Korea-based maker of an insulin patch pump. In its announcement of the deal Thursday, Medtronic suggested that integrating the tubeless device with its own continuous glucose monitors and meal-detection algorithm could create a new closed-loop system for largely hands-off diabetes management.
Apnimed started the year by bagging nearly $80 million in extended series C funds and the momentum has kept up, with the sleep-apnea-focused biotech nailing its goals in a phase 2 study. “For those who cannot tolerate current treatments, AD109 has the potential to be a convenient, oral pill that could improve people’s quality of life both at night and during the day.”